Guy Shalom, Devy Zisman, Haim Bitterman, Ilana Harman-Boehm, Sari Greenberg-Dotan, Jacob Dreiher, Ilan Feldhamer, Hadas Moser, Ariel Hammerman, Yoram Cohen, Arnon D Cohen
IMPORTANCE: The risk for herpes zoster (HZ) in patients with psoriasis treated with biologic medications or other systemic treatments has been given little attention to date. OBJECTIVE: To describe the risk for HZ in patients with psoriasis and its relation to treatment. DESIGN, SETTING, AND PARTICIPANTS: A cohort study was performed using the administrative database of Clalit Health Services, the largest public health care provider organization in Israel, in the setting of general community clinics, primary care and referral centers, and ambulatory and hospitalized care...
May 2015: JAMA Dermatology